Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies

Medical Dosimetry

Volumn 37, Issue 3, 2012, Pages 271-275

  Ali, Arif N ^a,b   Dhabaan, Anees H ^a,b   Jarrio, Christie S ^a,b   Siddiqi, Arsalan K ^a,b   Landry, Jerome C ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

IMRT; Pancreas; RapidArc; VMAT

Indexed keywords

CONTRAST MEDIUM;

ANALYTICAL PARAMETERS; ARTICLE; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; CONFORMALITY INDEX; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY; LIVER; MONITOR; ORGAN AT RISK VOLUME; PANCREAS CANCER; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EQUIPMENT; RADIOTHERAPY; RETROSPECTIVE STUDY; SMALL INTESTINE; SPINAL CORD; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC THERAPY;

ADULT; FEMALE; HUMANS; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84864761512     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2011.10.001     Document Type: Article

References (38)

1. Willett C.G., Czito B.G., Bendell J.C., et al. Cancer of the pancreas. Principles and Practice of Radiation Oncology 2008, Lippincott Williams & Wilkins, Philadelphia. E.C. Halperin, C.A. Perez, L.W. Brady (Eds.).
2. Steadham A.M., Liu H.H., Crane C.H., et al. Optimization of beam orientations and weights for coplanar conformal beams in treating pancreatic cancer. Med. Dosim. 1999, 24:265-271.
3. Landry J.C., Yang G.Y., Ting J.Y., et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (Vara): Employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med. Dosim. 2002, 27:121-129.
4. Milano M.T., Chmura S.J., Garofalo M.C., et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: Toxicity and clinical outcome. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:445-453.
5. Krempien R., Muenter M.W., Huber P.E., et al. Randomized phase II-study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer-PARC: Study protocol [ISRCTN56652283]. BMC Cancer 2005, 5:131.
6. Crane C.H., Antolak J.A., Rosen I.I., et al. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. Int. J. Gastrointest. Cancer 2001, 30:123-132.
7. van der Geld Y.G., van Triest B., Verbakel W.F., et al. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:1215-1220.
8. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008, 35:310-317.
9. Clivio A., Fogliata A., Franzetti-Pellanda A., et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother. Oncol. 2009, 92:118-124.
10. Cozzi L., Dinshaw K.A., Shrivastava S.K., et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother. Oncol. 2008, 89:180-191.
11. Fogliata A., Clivio A., Nicolini G., et al. Intensity modulation with photons for benign intracranial tumours: A planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother. Oncol. 2008, 89:254-262.
12. Kjaer-Kristoffersen F., Ohlhues L., Medin J., et al. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol. 2009, 48:227-232.
13. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:996-1001.
14. Vanetti E., Clivio A., Nicolini G., et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: A treatment planning comparison with fixed field IMRT. Radiother. Oncol. 2009, 92:111-117.
15. Eppinga W., Lagerwaard F.J., Verbakel W.F.A.R., et al. Conventional IMRT versus Volumetric Modulated Arc Therapy (RapidArc) for Pancreatic Cancer. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75:S712.
16. Verbakel W.F.A.R., Senan S., Lagerwaard F.J., et al. RapidArc vs. IMRT Planning: A Comparative Study with Dosimetric Validation for Head and Neck, glioma and Pancreas Cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:S596-S597.
17. Rao M., Yang W., Chen F., et al. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: Plan quality, delivery efficiency and accuracy. Med. Phys. 2010, 37:1350.
18. Mackie T.R., Holmes T., Swerdloff S., et al. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy. Med. Phys. 1993, 20:1709.
19. Brown M.W., Ning H., Arora B., et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:274-283.
20. Fogliata A., Yartsev S., Nicolini G., et al. On the performances of Intensity Modulated Protons, RapidArc and Helical Tomotherapy for selected paediatric cases. Radiol. Oncol. 2009, 4:2.
21. Cohen S.J., Dobelbower R., Lipsitz S., et al. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1345-1350.
22. Popescu C.C., Olivotto I.A., Beckham W.A., et al. Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:287-295.
23. Wolff D., Stieler F., Welzel G., et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother. Oncol. 2009, 93:226-233.
24. McGrath S.D., Matuszak M.M., Yan D., et al. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis. Radiother. Oncol. 2010, 95:153-157.
25. Matuszak M.M., Yan D., Grills I., et al. Clinical applications of volumetric modulated arc therapy. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77:608-616.
26. Shaffer R., Nichol A.M., Vollans E., et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:1177-1184.
27. Nicolini G., Clivio A., Fogliata A., et al. Simultaneous integrated boost radiotherapy for bilateral breast: A treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy. Radiat. Oncol. 2009, 4:27.
28. Wu Q.J., Yoo S., Kirkpatrick J.P., et al. Volumetric Arc Intensity-Modulated Therapy for Spine Body Radiotherapy: Comparison with Static Intensity-Modulated Treatment. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75:1596-1604.
29. Prah D. Su-e-J-142: A Comparison of TomoTherapy and Respiratory? Gated IG? IMRT for the Treatment of Pancreatic Cancer. Med. Phys. 2011, 38:3475.
30. Chargari C., Campana F., Beuzeboc P., et al. Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer. World J. Gastroenterol. 2009, 15:4444-4445.
31. Movahed A. WE-C-AUD C-05: Analysis of best fitting tomo treatment planning parameters for prostate, lung, breast, brain, liver, head & neck, breast, pelvis and pancreas lesions from our 3 years experience planning for nearly 1000 patients. Med. Phys. 2008, 35:2936.
32. Cao D. SU-FF-T-07: A comparison between intensity modulated arc therapy (IMAT) and tomotherapy. Med. Phys. 2006, 33:2052.
33. Chang D.T., Schellenberg D., Shen J., et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 2009, 115:665-672.
34. Rwigema J.-C.M., Parikh S.D., Heron D.E., et al. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am. J. Clin. Oncol. 2011, 34:63-69.
35. Koong A.C., Le Q.T., Ho A., et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:1017-1021.
36. Koong A.C., Christofferson E., Le Q.T., et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:320-323.
37. Schellenberg D., Goodman K.A., Lee F., et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:678-686.
38. Hoyer M., Roed H., Sengelov L., et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother. Oncol. 2005, 76:48-53.